LHRH-agonists in Early Breast Cancer Overview group (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive ...
In these cancers, estrogen can bind to receptors on cancer cells, fueling their growth and spread. Treatments for estrogen-dependent cancers often focus on reducing estrogen levels or blocking ...
Breast cancers sensitive to hormones are typically referred to as hormone receptor–positive (HR-positive) but may also be called hormone responsive or hormone dependent. How do hormones ...
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to ...